AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $216,000 | -26.0% | 7,700 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $292,000 | -14.6% | 7,700 | -12.3% | 0.00% | -20.0% |
| Q1 2019 | $342,000 | +3.0% | 8,775 | -43.6% | 0.01% | 0.0% |
| Q4 2018 | $332,000 | -49.9% | 15,550 | -7.2% | 0.01% | -37.5% |
| Q3 2018 | $663,000 | +3.6% | 16,750 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $640,000 | +43.5% | 16,750 | +12.8% | 0.01% | +33.3% |
| Q1 2018 | $446,000 | -0.4% | 14,850 | +3.5% | 0.01% | +20.0% |
| Q4 2017 | $448,000 | – | 14,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |